Philip S Wang

Summary

Publications

  1. ncbi The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    JAMA 289:3095-105. 2003
  2. ncbi Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Arch Gen Psychiatry 62:603-13. 2005
  3. pmc Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    Arch Gen Psychiatry 67:497-506. 2010
  4. pmc Changing profiles of service sectors used for mental health care in the United States
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 163:1187-98. 2006
  5. doi Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications
    Soko Setoguchi
    Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    J Am Geriatr Soc 56:1644-50. 2008
  6. ncbi Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes
    Wolfgang C Winkelmayer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Kidney Dis 46:1080-7. 2005
  7. pmc Individual and societal effects of mental disorders on earnings in the United States: results from the national comorbidity survey replication
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 165:703-11. 2008
  8. ncbi Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Arch Gen Psychiatry 62:629-40. 2005
  9. pmc Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 163:1561-8. 2006
  10. ncbi Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects?
    M Alan Brookhart
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital Harvard Medical School, Boston, Massachusetts, USA
    Med Care 45:S116-22. 2007

Detail Information

Publications62

  1. ncbi The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    JAMA 289:3095-105. 2003
    ..Uncertainties exist about prevalence and correlates of major depressive disorder (MDD)...
  2. ncbi Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Arch Gen Psychiatry 62:603-13. 2005
    ..An understudied crucial step in the help-seeking process is making prompt initial contact with a treatment provider after first onset of a mental disorder...
  3. pmc Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    Arch Gen Psychiatry 67:497-506. 2010
    ..This prompted a meta-analysis of trials in adults that found no overall increase in risk, but individual agents could not be studied...
  4. pmc Changing profiles of service sectors used for mental health care in the United States
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 163:1187-98. 2006
    ..Redesigning the fragmented U.S. mental health care system requires knowing how service sectors share responsibility for individuals' mental health needs...
  5. doi Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications
    Soko Setoguchi
    Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    J Am Geriatr Soc 56:1644-50. 2008
    ....
  6. ncbi Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes
    Wolfgang C Winkelmayer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Kidney Dis 46:1080-7. 2005
    ..However, little is known about the adequacy of adherence to these guidelines in elderly patients with diabetes and predictors of such appropriate ACE-inhibitor or ARB use...
  7. pmc Individual and societal effects of mental disorders on earnings in the United States: results from the national comorbidity survey replication
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 165:703-11. 2008
    ..The purpose of this report was to update previous estimates of the association between mental disorders and earnings. Current estimates for 2002 are based on data from the National Comorbidity Survey Replication (NCS-R)...
  8. ncbi Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Arch Gen Psychiatry 62:629-40. 2005
    ..Dramatic changes have occurred in mental health treatments during the past decade. Data on recent treatment patterns are needed to estimate the unmet need for services...
  9. pmc Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 163:1561-8. 2006
    ..Bipolar disorder has been overlooked both because of the failure to distinguish between major depressive disorder and bipolar disorder and by the failure to evaluate the workplace costs of mania/hypomania...
  10. ncbi Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects?
    M Alan Brookhart
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital Harvard Medical School, Boston, Massachusetts, USA
    Med Care 45:S116-22. 2007
    ..We sought to explore the validity of physician-level IV in a comparative study of short-term mortality risk among elderly users of conventional versus atypical antipsychotic medications (APM)...
  11. pmc Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Gigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    J Gen Intern Med 19:444-50. 2004
    ..We sought to evaluate and rank the performance of comorbidity scores across selected U.S. and Canadian elderly populations using health care utilization databases...
  12. ncbi Risk of death in elderly users of conventional vs. atypical antipsychotic medications
    Philip S Wang
    Department of Psychiatry, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    N Engl J Med 353:2335-41. 2005
    ..However, the advisory did not apply to conventional antipsychotic medications; the risk of death with these older agents is not known...
  13. ncbi Assessing health state utilities in elderly patients at cardiovascular risk
    Wolfgang C Winkelmayer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Med Decis Making 26:247-54. 2006
    ..Health state preferences can be a crucial component of cost-effectiveness analyses, but off-the-shelf health state utilities specifically for older people are not available...
  14. ncbi The costs and benefits of enhanced depression care to employers
    Philip S Wang
    Department of Psychiatry, Brigham and Women s Hospital, 75 Francis Street, Boston, MA, USA
    Arch Gen Psychiatry 63:1345-53. 2006
    ..Although outreach and enhanced treatment interventions improve depression outcomes, uptake has been poor in part because purchasers lack information on their return on investment...
  15. pmc When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study
    Roy H Perlis
    Center for Human Genetics Research, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Neuropsychopharmacology 34:2227-36. 2009
    ..These circumstances, particularly availability of alternative treatment strategies and test effect sizes, can be estimated and should be considered before these tests are broadly applied in clinical settings...
  16. ncbi Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Hypertension 46:273-9. 2005
    ..Highly prevalent, noncardiovascular conditions appear to deter use of antihypertensives in elderly with hypertension...
  17. pmc Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts
    Sebastian Schneeweiss
    Harvard Medical School, Brigham and Women s Hospital, Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Boston, MA 02120, USA
    Pediatrics 125:876-88. 2010
    ..The objective of this study was to assess the risk of suicide attempts and suicides after initiation of antidepressant medication use by children and adolescents, for individual agents...
  18. ncbi Effects of major depression on moment-in-time work performance
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 161:1885-91. 2004
    ..The authors used the experience sampling method to address this problem by collecting comparative data on moment-in-time work performance among service workers who were depressed and those who were not depressed...
  19. ncbi Self-management education programs in chronic disease: a systematic review and methodological critique of the literature
    Asra Warsi
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02120, USA
    Arch Intern Med 164:1641-9. 2004
    ..We evaluated the efficacy of patient self-management educational programs for chronic diseases and critically reviewed their methodology...
  20. ncbi Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Annu Rev Clin Psychol 3:137-58. 2007
    ..The article closes with a discussion of future directions for research...
  21. ncbi Racial differences in screening for prostate cancer in the elderly
    Timothy Gilligan
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Arch Intern Med 164:1858-64. 2004
    ..Low screening rates among black men may contribute to these disparities, but there are few data on racial differences in prostate cancer screening...
  22. ncbi Use of the case-crossover design to study prolonged drug exposures and insidious outcomes
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Ann Epidemiol 14:296-303. 2004
    ..We investigated whether case-crossover methods can be used to study prolonged exposures and insidious outcomes...
  23. pmc Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School, Brigham and Women s Hospital, Boston, Massachusetts, USA
    CNS Drugs 23:171-80. 2009
    ..Nonrandomised studies on the causal effects of psychotropic medications may be biased by patient characteristics that are not fully adjusted...
  24. doi The descriptive epidemiology of commonly occurring mental disorders in the United States
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Annu Rev Public Health 29:115-29. 2008
    ....
  25. ncbi Prescription opioid use among older adults with arthritis or low back pain
    Daniel H Solomon
    Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Ste, 3030, Boston, MA 02120, USA
    Arthritis Rheum 55:35-41. 2006
    ..To examine patterns of chronic opioid use in selected groups with arthritis and low back pain and compare them with patterns among persons with ischemic heart disease...
  26. ncbi Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic model
    Roy H Perlis
    Pharmacogenomics Research Program, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    J Clin Psychopharmacol 25:427-34. 2005
    ..More consistent reporting of test parameters such as sensitivity and specificity would greatly facilitate assessment of future pharmacogenetic studies...
  27. ncbi Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis
    Sebastian Schneeweiss
    Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics, Boston, MA 021205, USA
    Arthritis Rheum 54:3390-8. 2006
    ....
  28. pmc Delays in initial treatment contact after first onset of a mental disorder
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Health Serv Res 39:393-415. 2004
    ..To examine nationally representative patterns and predictors of delays in contacting a professional after first onset of a mental disorder...
  29. ncbi Instrumental variable analysis of secondary pharmacoepidemiologic data
    M Alan Brookhart
    Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women s Hospital, Boston, MA 02120, USA
    Epidemiology 17:373-4. 2006
  30. ncbi Selective prescribing led to overestimation of the benefits of lipid-lowering drugs
    Robert J Glynn
    Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Clin Epidemiol 59:819-28. 2006
    ..Selective use of these drugs in frail people may confound these relationships...
  31. ncbi Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Occup Environ Med 45:1303-11. 2003
    ..Disease management programs for these conditions might have a positive return on investment (ROI). Health and productivity tracking surveys are needed to evaluate ROI and provide quality assurance...
  32. pmc The prevalence and correlates of workplace depression in the national comorbidity survey replication
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    J Occup Environ Med 50:381-90. 2008
    ..To review evidence on the workplace prevalence and correlates of major depressive episodes, with a particular focus on the National Comorbidity Survey Replication, the most recent national survey to focus on these issues...
  33. pmc Improved comorbidity adjustment for predicting mortality in Medicare populations
    Sebastian Schneeweiss
    Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Health Serv Res 38:1103-20. 2003
    ..To define and improve the performance of existing comorbidity scores in predicting mortality in Medicare enrollees...
  34. pmc Patterns and correlates of contacting clergy for mental disorders in the United States
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Health Serv Res 38:647-73. 2003
    ..To present nationally representative data on the part played by clergy in providing treatment to people with mental disorders in the United States...
  35. pmc Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 021205, USA
    CMAJ 176:627-32. 2007
    ..We assessed the short-term mortality in a population-based cohort of elderly people in British Columbia who were prescribed conventional and atypical antipsychotic medications...
  36. pmc The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
    Epidemiol Psichiatr Soc 18:23-33. 2009
    ..The paper reviews recent findings from the WHO World Mental Health (WMH) surveys on the global burden of mental disorders...
  37. pmc Disruption of existing mental health treatments and failure to initiate new treatment after Hurricane Katrina
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 165:34-41. 2008
    ..The authors examined the disruption of ongoing treatments among individuals with preexisting mental disorders and the failure to initiate treatment among individuals with new-onset mental disorders in the aftermath of Hurricane Katrina...
  38. ncbi Restrictions on antidepressant medications for children: a review of Medicaid policy
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA
    Psychiatr Serv 58:135-8. 2007
    ..This study evaluated Medicaid's prior-authorization policies restricting the prescribing of antidepressant medications for children...
  39. pmc Identification of hospitalizations for intentional self-harm when E-codes are incompletely recorded
    Amanda R Patrick
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Pharmacoepidemiol Drug Saf 19:1263-75. 2010
    ..However, rates of E-code completeness in US government and commercial claims databases are low due to issues with hospital billing software...
  40. ncbi Considering the costs of bipolar depression
    Ronald C Kessler
    Harvard Medical School, USA
    Behav Healthc 27:45-7. 2007
  41. pmc Health advisories and patterns of patient monitoring among new users of antidepressant medications
    Joshua J Gagne
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Suite 3030, 1620 Tremont St, Boston, MA 02120, USA
    J Clin Psychopharmacol 29:590-4. 2009
    ..We sought to identify patterns of patient monitoring after antidepressant initiation in British Columbia before and after issuance of health advisories...
  42. ncbi Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, Mass 02115, USA
    JAMA 293:2487-95. 2005
    ..Little is known about trends in suicidal ideation, plans, gestures, or attempts or about their treatment. Such data are needed to guide and evaluate policies to reduce suicide-related behaviors...
  43. ncbi Suboptimal antidepressant use in the elderly
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    J Clin Psychopharmacol 25:118-26. 2005
    ..Suboptimal antidepressant use remains common in the elderly, especially the use of inadequately intensive regimens. Interventions are needed to improve the quality and outcomes of antidepressant use in this vulnerable population...
  44. pmc Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable
    M Alan Brookhart
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital Harvard Medical School, Boston, MA 02120, USA
    Epidemiology 17:268-75. 2006
    ..Instrumental variable methods have been proposed as a potential approach to control confounding by indication in nonexperimental studies of treatment effects; however, good instruments are hard to find...
  45. ncbi Lipid levels and bone mineral density
    Daniel H Solomon
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02120, USA
    Am J Med 118:1414. 2005
    ..The aim of this study was to examine the relationship between lipid levels and bone mineral density...
  46. ncbi Medicaid's prior authorization program and access to atypical antipsychotic medications
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Health Aff (Millwood) 26:750-60. 2007
    ..More than a year later, no state had changed its PA policy in response. We discuss the roles of Medicaid and other insurers in responding to emerging drug safety issues and their challenges in weighing drug risks and benefits...
  47. ncbi Dopamine antagonists and the development of breast cancer
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 221 Longwood Ave, Boston, MA 02115, USA
    Arch Gen Psychiatry 59:1147-54. 2002
    ..Although animal studies have raised the possibility that prolactin-elevating dopamine antagonists used to treat psychotic disorders may initiate and promote breast cancers, epidemiologic studies in humans have been limited and inconsistent...
  48. ncbi Claims data studies of sedative-hypnotics and hip fractures in older people: exploring residual confounding using survey information
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Geriatr Soc 53:948-54. 2005
    ..To identify the magnitude of confounding bias caused by factors not measured in claims data studies of sedative-hypnotic use and fractures...
  49. ncbi Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    J Clin Psychopharmacol 24:632-8. 2004
    ..Using survey data, we determined the magnitude of such bias and corrected the association between SSRI use and hip fractures accordingly...
  50. ncbi Distinguishing generalized anxiety disorder from major depression: prevalence and impairment from current pure and comorbid disorders in the US and Ontario
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston MA 02115, USA
    Int J Methods Psychiatr Res 11:99-111. 2002
    ..The paper closes with a discussion of the methodological complexities associated with generalizing to comorbidities that involve rare conditions or more than two disorders...
  51. ncbi Psychotropic medication use for behavioral symptoms of dementia
    Philip S Wang
    Department of Psychiatry, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    Curr Neurol Neurosci Rep 6:490-5. 2006
    ..Also, although various psychotropic medications used for behavioral disturbances in dementia patients may be somewhat effective, they have been increasingly associated with important safety risks...
  52. ncbi Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial
    Jerry Avorn
    Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Control Clin Trials 23:757-73. 2002
    ....
  53. ncbi Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
    Ann H Partridge
    Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney Street, D1210, Boston, MA 02215, USA
    J Clin Oncol 21:602-6. 2003
    ..We sought to estimate adherence and predictors of nonadherence in women starting tamoxifen as adjuvant breast cancer therapy...
  54. ncbi How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 13:11-9. 2004
    ..Although self-reports are often the only means available in routine practice, their accuracy and agreement with other data sources remain questionable...
  55. ncbi The economic burden of depression and the cost-effectiveness of treatment
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Int J Methods Psychiatr Res 12:22-33. 2003
    ..Further research is needed to overcome these barriers to providing high-quality care for depression and to ultimately reduce the enormous adverse economic impact of depression disorders...
  56. ncbi Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Geriatr Soc 50:117-24. 2002
    ..We sought to determine whether the use of urinary antispasmodics increases the risk of ventricular arrhythmias or sudden death...
  57. ncbi Statin lipid-lowering drugs and bone mineral density
    Daniel H Solomon
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    Pharmacoepidemiol Drug Saf 14:219-26. 2005
    ..We examined the relationship between statin use and bone density among postmenopausal women...
  58. ncbi Effects of efforts to increase response rates on a workplace chronic condition screening survey
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Med Care 40:752-60. 2002
    ..We evaluated these concerns by examining the prevalences and work impairments associated with chronic conditions across four HRA subsamples that differed in intensity of recruitment effort...
  59. ncbi Parental anxiety associated with referral of a child to a pediatric cardiologist for evaluation of a Still's murmur
    Robert L Geggel
    Department of Cardiology, Children s Hospital, Boston, Massachusetts 02115, USA
    J Pediatr 140:747-52. 2002
    ..We assessed factors contributing to parental anxiety when children are referred to a cardiology clinic for evaluation of a Still's murmur...
  60. ncbi Arthritis self-management education programs: a meta-analysis of the effect on pain and disability
    Asra Warsi
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, 221 Longwood Avenue, Suite 341, Boston, MA 02115, USA
    Arthritis Rheum 48:2207-13. 2003
    ..Some reports suggest that education programs help arthritis patients better manage their symptoms and improve function. This review of the published literature was undertaken to assess the effect of such programs on pain and disability...
  61. pmc Adequacy of treatment for serious mental illness in the United States
    Philip S Wang
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Public Health 92:92-8. 2002
    ..The purpose of this study was to assess the prevalence and correlates of treatment for serious mental illness...
  62. ncbi Clozapine use and risk of diabetes mellitus
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Clin Psychopharmacol 22:236-43. 2002
    ..Additional data from pharmacoepidemiologic studies and randomized controlled trials are needed to exclude the possibility of residual confounding and ensure the appropriate use of this agent...